Task: Answer the MCQ question.
Question: Which compound exhibits a -14.563% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21
b O=C(O)c1ccc(-n2cccc2/C=C2/SC(=O)N(CC(=O)N3CCCC3)C2=O)cc1
Answer: a. CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21
CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21
N-phenyl-4-(1-propan-2-ylbenzimidazol-2-yl)piperazine-1-carboxamide